Wall Street sent mixed signals on D-Wave Quantum this week. B. Riley raised its price target to $40, citing the company’s dual-technology roadmap, while Stifel held firm at $35 after absorbing the same investor presentation. The stock, meanwhile, shed 7.8% on June 3 to $27.568 and dropped another 8.26% in Frankfurt to €23.67, leaving the monthly gain at a still-substantial 32.09%. The tension is clear: the strategic narrative is strengthening, but the market is demanding concrete financial proof.
The first investor day on June 2 gave analysts something to work with beyond qubit counts. D-Wave laid out specific gross margin corridors for the first time — between 65% and 75% for Quantum Computing-as-a-Service, 40% to 50% for professional services, and a hefty 75% to 90% for quantum computing systems. These ranges give investors a framework to judge future quarterly reports, shifting the focus from pure roadmaps to operational economics.
On the capacity side, D-Wave operates four annealing quantum computers supporting its Leap cloud service, translating to an annual revenue capacity of $100 million to $120 million. Management also disclosed that each production annealing system costs roughly $2 million and can be built and calibrated in under four months. That level of capital efficiency matters for a company whose stock trades at a market cap of about $10.2 billion and carries a 30-day annualized volatility of 135.53%.
The customer pipeline is gaining texture. D-Wave listed 26 publicly disclosed customers from the past 18 months, including Anduril Industries, AT&T, BASF, Boeing, Pfizer, NTT Docomo, and the U.S. Army Engineer Research and Development Center. That list helps anchor the narrative that quantum computing is migrating from labs into commercial workflows. Sales staff with quotas grew 220% over the same period, while the technical solutions team expanded 129%.
Bookings provided the strongest forward-looking signal. First-quarter bookings hit $33.4 million, a massive leap from the prior year, propelled by two standout deals: a $20 million system purchase from Florida Atlantic University and a $10 million two-year cloud contract with a Fortune 100 company. Remaining performance obligations ended March at $42.4 million, with about 54% expected to convert into revenue over the next 12 months.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
Yet the income statement tells a blunter story. First-quarter revenue came in at just $2.9 million, down from $15 million a year earlier when a system sale boosted the top line. That disparity underscores why the stock’s valuation remains contested. D-Wave can land large contracts, but revenue recognition is lumpy, making quarterly comparisons volatile.
Financial cushion provides some breathing room. The company ended the quarter with $588.4 million in liquidity, though it deployed $250 million of that for the acquisition of Quantum Circuits. On the funding front, D-Wave secured a non-binding letter of intent from the U.S. Department of Commerce for $100 million under the CHIPS and Science Act, with the government taking a minority stake in exchange. The funds are earmarked for scaling: an annealing system with 100,000 qubits and a gate-model system targeting 10,000 qubits — roughly 100 logical qubits — with the gate-model roadmap stretching from 2026 to 2032, when fault-tolerant systems are envisioned.
The competitive picture sharpened this week as Quantinuum began trading on the Nasdaq Global Market on June 4 under the ticker QNT. The IPO priced at $60, with 28 million Class A shares placed, generating gross proceeds of approximately $1.68 billion. That creates a fresh valuation benchmark for the quantum sector. D-Wave’s own $10.2 billion market cap will now be judged against Quantinuum’s market reception and the differing technology approaches each company pursues.
Analyst sentiment remains skewed to the buy side. Roth Capital and Needham both set $40 targets, Rosenblatt Securities tops out at $43, and the consensus sits at $37.50 across 11 buy ratings and one hold. Stifel left its estimates unchanged after the investor day, a subtle signal that the presentation reinforced the long-term thesis without triggering near-term forecast adjustments.
D-Wave’s stock trades 34.73% above its 50-day moving average and 14.85% above its 200-day line, yet it still sits 38.49% below its 52-week high. The next hurdle is straightforward: convert a $33.4 million bookings quarter and a $42.4 million backlog into recurring revenue that matches the margin targets and capacity numbers management has now put on the table.
Ad
D-Wave Quantum Stock: Buy or Sell?! New D-Wave Quantum Analysis from June 4 delivers the answer:
The latest D-Wave Quantum figures speak for themselves: Urgent action needed for D-Wave Quantum investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 4.
D-Wave Quantum: Buy or sell? Read more here...
